Spotlight on Antibodies | Episode 8 | August 1-31, 2025

Spotlight on Antibodies is a podcast from ⁠⁠Biointron⁠⁠, where we bring you the latest antibody industry trends. This August, we highlight drug advances in autoimmune and infectious diseases, as well as next-generation immune cell engagers.

References:

1. Pelkas, C., Franke, K. B., Vincent, F. B., & Rischmueller, M. (2025). Novel therapies in Sjögren’s disease: A systematic review of the literature. Best Practice & Research Clinical Rheumatology, 102084. ⁠https://doi.org/10.1016/j.berh.2025.102084⁠

2. Subramaniam, S., Saville, J. W., Feng, F., & Freiburger, L. (2025). Therapeutic Antibodies for Infectious Diseases: Recent Past, Present, and Future. Biochemistry. ⁠https://doi.org/10.1021/acs.biochem.5c00192⁠

3. Atanasov, P. Y., Moneva-Sakelarieva, M. G., Kobakova, Y. A., Ivanova, S. A., Becheva, M. V., Kirkova-Bogdanova, A. G., Chaneva, M. S., Atanasova, V. P., Todorov, R. F., Bashev, N. Z., Bashov, I. E., & Ibrahim, A. H. (2025). Monoclonal antibodies: their place in applied medicine and their role in the newest infectious disease – history, present, and future. Literature review. Pharmacia, 72, 1–18. ⁠https://doi.org/10.3897/pharmacia.72.e159772⁠

4. Fucà, G., Spagnoletti, A., Ambrosini, M., De Braud, F., & Di Nicola, M. (2021). Immune cell engagers in solid tumors: Promises and challenges of the next generation immunotherapy. ESMO Open, 6(1), 100046. ⁠https://doi.org/10.1016/j.esmoop.2020.100046⁠

5. In, H., Park, M., Lee, H., & Han, K. H. (2025). Immune Cell Engagers: Advancing Precision Immunotherapy for Cancer Treatment. Antibodies, 14(1), 16. ⁠https://doi.org/10.3390/antib14010016⁠

6. Albayrak, G., Wan, P. K., Fisher, K., & Seymour, L. W. (2025). T cell engagers: Expanding horizons in oncology and beyond. British Journal of Cancer, 1-9. ⁠https://doi.org/10.1038/s41416-025-03125-y‌